Romania’s interim government has allocated an additional € 66.5 million (329 million RON) from its reserve fund to support the health sector hit by COVID.
The Polish Government and the National Health Fund made amendments to the healthcare budget plan.
At the 4th Western Balkan Digital Summit (11-13 October 2021, Podgorica, Montenegro), attended by representatives from the Western Balkan (WB) countries, WHO Regional Director, Dr Hans Hanri P. Kluge, made several strategic statements regarding development of the healthcare system in the Western Balkan region.
An amendment to the law on publicly financed health care services, recently published in Journal of Laws of the Republic of Poland, envisages a gradual increase on healthcare spending from 5,75% of GDP in 2022 to 6,8% of GDP in 2026.
The e-PIL pilot project seeks to assess whether the introduction of electronic package leaflets (e-PILs) instead of printed labels with the view to ensure the safe use of hospital medicinal products and increase their availability.
The healthcare distribution sector in Poland has undergone considerable changes in recent years with consolidation and privatization driving change and leading wholesale players maximising national reach and market share.
Cost containment measures including price and reimbursement cuts are putting pharmaceutical manufactures under increased pressure and tougher market conditions are evident in Central and Eastern Europe. The current reimbursement environment in many CEE countries continues to pose challenges for all pharma market players, including producers and distributors of medicinal products alike.
As of the end of 2017, active work on legislation change and update is going on in Kazakhstan in the area of healthcare and pharmaceutical business. Such legislative activity is aimed at harmonizing the laws of the Republic of Kazakhstan
Last week, on July 10, 2018, in Sofia VladislavShestakov–Director of the State Institute of Drugs and Good Practices, Deputy Head of the State GMP Inspectorate met with Professor AssenaStoimenova, Executive Director of the Bulgarian Drug Agency (Medicines Agency of the Bulgarian Health Ministry).
Aurobindo Pharma to acquire Apotex’ businesses in Poland, Czech Republic, the Netherlands, Spain and Belgium
Aurobindo Pharma announced that its wholly owned step-down subsidiary, Agile Pharma B. V. (Netherlands) has entered into an agreement on 13 July 2018 to acquire commercial operations and certain supporting infrastructure in five European countries viz. the Netherlands, Belgium, Spain, Poland and